Humana Antibody-Drug Conjugates and Immunotoxins Book

Explore the evolution of targeted cancer treatments with Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications. This specialized volume brings together leading research on antibody-drug conjugates (ADCs) and immunotoxins (ITs), providing a comprehensive look at the transition from early concepts to modern medical realities. Since Paul Ehrlich first proposed the idea of magic bullets, the field has transformed through the approval of monoclonal antibody therapies. This book tracks that progress, examining every stage of the process from clinical development to the latest technological advancements in the field. It is an essential resource for those studying how monoclonal antibodies are linked to potent cytotoxic agents to create highly targeted therapies. Whether you are researching cancer drug discovery or studying the development of targeted therapeutic applications, this text provides a deep look into the science of delivering medicine directly to diseased cells. It covers the technical aspects of conjugation and the clinical pathways required to bring these advanced therapies to patients.